Novavax | NVAX - أصول متداولة





أصول متداولة تغيير تاريخ
Adma Biologics USD 511.17M 44.66M 2026-03
Agenus USD 95.28M 38.15M 2026-03
AstraZeneca USD 29.61B 890M 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
Cassava Sciences USD 87.96M 9.74M 2026-03
Geron USD 498.53M 21.74M 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
MannKind USD 251.16M 40.42M 2026-03
Merck USD 35.02B 8.5B 2026-03
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Moderna USD 5.77B 774M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Novavax USD 850.82M 127.46M 2026-03
Pfizer USD 42.82B 76M 2026-03
Sanofi EUR 30.16B 789M 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
TG Therapeutics USD 1.09B 456.2M 2026-03